GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » E10

Sinphar Pharmaceutical Co (TPE:1734) E10 : NT$0.54 (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was NT$0.450. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$0.54 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Sinphar Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sinphar Pharmaceutical Co was 1.50% per year. The lowest was -4.50% per year. And the median was -1.50% per year.

As of today (2025-03-25), Sinphar Pharmaceutical Co's current stock price is NT$31.95. Sinphar Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was NT$0.54. Sinphar Pharmaceutical Co's Shiller PE Ratio of today is 59.17.

During the past 13 years, the highest Shiller PE Ratio of Sinphar Pharmaceutical Co was 123.15. The lowest was 25.50. And the median was 65.11.


Sinphar Pharmaceutical Co E10 Historical Data

The historical data trend for Sinphar Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co E10 Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.40 0.47 0.47 0.54

Sinphar Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.50 0.49 0.53 0.54

Competitive Comparison of Sinphar Pharmaceutical Co's E10

For the Biotechnology subindustry, Sinphar Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinphar Pharmaceutical Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinphar Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sinphar Pharmaceutical Co's Shiller PE Ratio falls into.



Sinphar Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sinphar Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.45/133.1571*133.1571
=0.450

Current CPI (Dec. 2024) = 133.1571.

Sinphar Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201503 -0.142 99.621 -0.190
201506 -0.053 100.684 -0.070
201509 -0.093 100.392 -0.123
201512 0.361 99.792 0.482
201603 -0.093 100.470 -0.123
201606 -0.009 101.688 -0.012
201609 -0.037 101.861 -0.048
201612 0.230 101.863 0.301
201703 -0.046 102.862 -0.060
201706 0.056 103.349 0.072
201709 0.074 104.136 0.095
201712 0.120 104.011 0.154
201803 0.093 105.290 0.118
201806 -0.009 106.317 -0.011
201809 -0.083 106.507 -0.104
201812 0.037 105.998 0.046
201903 0.083 107.251 0.103
201906 -0.139 108.070 -0.171
201909 -0.056 108.329 -0.069
201912 0.185 108.420 0.227
202003 0.148 108.902 0.181
202006 0.046 108.767 0.056
202009 -0.056 109.815 -0.068
202012 -0.296 109.897 -0.359
202103 0.028 111.754 0.033
202106 0.028 114.631 0.033
202109 -0.185 115.734 -0.213
202112 -0.083 117.630 -0.094
202203 0.324 121.301 0.356
202206 0.481 125.017 0.512
202209 0.380 125.227 0.404
202212 0.065 125.222 0.069
202303 0.444 127.348 0.464
202306 0.602 128.729 0.623
202309 0.420 129.860 0.431
202312 0.610 129.419 0.628
202403 0.611 131.776 0.617
202406 0.361 132.554 0.363
202409 0.260 133.029 0.260
202412 0.450 133.157 0.450

Add all the adjusted EPS together and divide 10 will get our e10.


Sinphar Pharmaceutical Co  (TPE:1734) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sinphar Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=31.95/0.54
=59.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sinphar Pharmaceutical Co was 123.15. The lowest was 25.50. And the median was 65.11.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sinphar Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Sinphar Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinphar Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines